Evoke Pharma Launches Gimoti® Patient and Physician Experience Program
14 juil. 2021 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma, EVERSANA and The International Foundation for Gastrointestinal Disorders Announce Membership into IFFGD’s Industry Council
29 juin 2021 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., CHICAGO, and MOUNT PLEASANT, S.C., June 29, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for...
Evoke Pharma and EVERSANA Announce Positive Findings from Second GIMOTI® Market Research Study
15 juin 2021 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, June 15, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases,...
Evoke Pharma and EVERSANA Launch Social Media Campaign for Gimoti® Nasal Spray
27 mai 2021 08h30 HE
|
Evoke Pharma, Inc.
Evoke is committed to meeting patients online, where they search for answers New campaign leverages Facebook to satisfy significant unmet need for education and community SOLANA BEACH, Calif. and...
Evoke Pharma Appoints Vickie Reed to Board of Directors
14 mai 2021 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...